KREBSTHERAPIE

European patent · EP3768830 · In force

Register entry

Publication number
EP3768830
Application number
EP19712179
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 19, 2019
Published
Jan 27, 2021
Granted
Jan 25, 2023
Protection ends at the latest
Mar 18, 2039
Next annual fee due
Mar 31, 2027
IPC classes
C12N 7/00 (2006.01)
C12N 15/86 (2006.01)
A61K 39/00 (2006.01)
A61K 35/761 (2015.01)
Priority
GB 201804468 21.03.2018
GB 201814866 13.09.2018
PCT application
PCT/EP2019/056770 19.03.2019
PCT publication
WO2019/179979 26.09.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  2. Apr 1, 2025

    Change

    Published in Swissreg on 01.04.2025

  3. Apr 1, 2024

    Change

    Published in Swissreg on 01.04.2024

  4. Dec 6, 2023

    Change

    Published in Swissreg on 06.12.2023

  5. Apr 1, 2023

    Change

    Published in Swissreg on 01.04.2023

  6. Feb 10, 2023

    Agent entered

    Representative
    MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex

    Published in Swissreg on 10.02.2023

  7. Jan 25, 2023

    Granted

    Published in Swissreg on 25.01.2023

Parties

Holder

Valo Therapeutics Oy

Cultivator 1 Viikinkaari 6, 00790 Helsinki, FI

Agent

MICHELI & CIE SA

122, rue de Genève, CP 61, 1226 Thônex

Inventor

PRIHA, Petri

00790 Helsinki, FI

MARTINS, Beatriz

00790 Helsinki, FI

PESONEN, Sari

00790 Helsinki, FI

YLÖSMÄKI, Erkko

00790 Helsinki, FI

RANKI, Tuuli

00790 Helsinki, FI

CERULLO, Vincenzo

00790 Helsinki, FI

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.